/EIN News/ — VANCOUVER, British Columbia, Oct. 03, 2023 (GLOBE NEWSWIRE) — Cannabix Technologies Inc. (CSE: BLO) (OTC PINK: BLOZF) (the “Company or Cannabix”) developer of marijuana and alcohol breath testing devices is pleased to report that its Mass Spectrometer Breath Sampler (“MSBS”) technology along with the Breath Collection Unit (“BCU”) have been used to quantify delta-9 THC levels from smoking and edibles in humans. This emerging capability is a significant milestone and a major leap forward in the arena of drug testing. Virtually all levels of law enforcement, government, and industry have an interest in quantifying THC levels in breath in an efficient and reliable manner which will enable the ability to correlate breath concentrations with established blood levels.
Cannabix has been focused on developing the MSBS as a simple effective way to test for recent use of marijuana and to confirm presence of delta-9 THC in breath using gold-standard mass spectrometry (MS). Over recent months, the Company has developed the capability to quantify delta-9 THC in breath samples using Cannabix’s proprietary technology.
Highlights and Updates
- The ability to efficiently and reliably quantify THC in breath has been a long-standing goal of researchers and industry and holds potentially wide raging benefits to society.
- Cannabix scientists have quantified delta-9 THC in human…
Original Author Link click here to read complete story..
